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Table 1. Characteristic features of the patients
Age (yearSD) 57,2112,45
Female (%) 66,9
Hypertension (%) 51,2
Hyperlipidemia (%) 31
Diabetes (%) 16,9
Coronary Heart Disease (%) 23,4
Heart Failure (%) 7,3
Chronic Kidney Disease (%) 19,4
HASBLED score (nSD) 1,541,08
Warfarin Dose (mg/weekSD) 33,3315,38
Mean TTR (%) 55,9227,84
Patients whose TTR > %60 (%) 48
History of thromboembolic or bleeding
complications (%)
49,6
Warfarin usage (yearSD) 7,486,18
INR checking per year 10,023,80
INR: _Internatiõonal Normalized Ratio, SD: Standart deviation, TTR: Time in Therapeutic Range
Table 2. Characteristic features of the patients according to warfarin
indications
Characteristic features of the patients
Prosthetic
valve Valvular AF Nonvalvular AF p value
Age (yearSD) 52,9611,24 57,9711,96 68,827,77 0,013
Female (%) 64,8 97,0 55,4 <0,001
Hypertension (%) 40,3 45,5 85,7 <0,001
Diabetes (%) 11,9 27,3 25,0 o,019
Coronary Heart Disease (%) 20,1 12,1 39,3 0,004
Heart Failure (%) 20,1 3,0 16,1 0,014
HASBLED score (nSD) 1,420,9 1,361,19 2,001,17 0,030
Warfarin Dose (mg/weekSD) 35,5816,90 31,6811,05 27,9211,18 0,004
Warfarin usage (yearSD) 9,496,58 3,822,47 3,913,31 <0,001
History of thromboembolic or bleeding
complications (%)
56,0 39,4 37,5 0,027
INR checking per year 9,993,94 10,524,10 9,823,19 0,558
Mean TTR (%) 55,2428,53 61,4825,90 54,5927,01 0,668
Patients whose TTR >%60 (%) 47,2 51,5 48,2 0,901
AF: Atrial ﬁbrillation, INR: _Internatiõonal Normalized Ratio, SD: Standart deviation, TTR: Time
in Therapeutic Range
Table 3. Mean TTR and effective TTR according to weekly warfarin dose
weekly warfarin
dose
Mean TTR*
(%SD)
TTR** (%)
<%60
TTR** (%)
%60
<15 mg 53,7628,82 57,1 42,9
15 mg 56,1227,80 %51,5 %48,5
TTR: Time in Therapeutic Range * p:0,623, ** p:0,711
Table 4. Mean TTR and TTR efﬁcacy versus complication history
Complication
History
Mean TTR*
(%SD)
TTR** (%)
<%60
TTR** (%)
%60
Absent 55,9127,8 52,8 47,2
Present 55,9327,9 51,2 48,8
*p:0,995, ** p:0,803 SD: Standart deviation, TTR: Time in Therapeutic Range
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Introductıon: Despite improved treatment modalities, the prognosis of pulmonary
hypertension due to connective tissue disease such as scleroderma is very high. In thisC128 JACC Vostudy, we evaluate factors that affect pulmonary artery pressure in scleroderma
patients with pulmonary hypertension
Materıals-Methods: 24 scleroderma patients with pulmonary hypertension were
included in this study. Detailed history was taken, physical examination and elec-
trocardiography performed and pulmonary hypertension was diagnosed by trans-
thoracic echocardiography along with right heart catheterization during which
systolic, diastolic and mean pulmonary artery pressures were measured. High reso-
lution tomography was used to diagnose interstitial pulmonary disease and inﬂam-
matory markers and autoantibodies were also measured. Factors that can be affected
on pulmonary artery pressure were evaluated with Spearman's rho test and Cox
regression analysis.
Results: A total of 24 patients, 19 were women (79%). In univariate analysis, there is
a positive correlation between pulmoary artery pressure and body mass index, right
ventricular diastolic diameter and BNP levels and also there is a negative correlation
between pulmonary artery pressure and presence of hypertension and white blood cell
count. In multivariate analysis, there is positive correlation between only right
ventricular diastolic diameter (r¼0,649, p<0,0001) and negative correlation between
presence of hypertension (r¼-0,502, p¼0,002).
Dıscussıon: Pulmonary hypertension accompanying scleroderma seriously decreases
the survival of these patients. Pulmoary artery pressure is an important factor in these
patients’ clinical course. Thus patients who have more elevated pulmonary artery
pressure may be follewed earlier, more intense and with combination therapy. In this
study, it was shown that there are strong correlations between right ventricular dia-
stolic diameter, presence of hypertension and pulmonary artery pressure in sclero-
derma patients with pulmonary hypertension.
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Introductıon: Scleroderma is a chronic, autoimmune disease that leads to ﬁbrosis of
the skin and visceral organs. Tp-e/QTc ratio, that reveals transmural repolarization and
arrhythmogenesis, is a new, highly reliable parameter, that can be used to determine
individuals with a high risk of ventricular arrhythmias. In this study, Tp-eQTc ratio
was calculated in scleroderma patients with and without pulmonary hypertension and
the difference between the two groups as well as the relation of this parameter with
mortality was sought for.
Materıals-Methods: A total of 160 scleroderma patients were includes in this study.
From the 12-derivation ECG of each patient, the interval between the peak (Tp) and
the end of the T wave (Te) was calculated and the difference was used to obtain a ratio
with QTc. Independent t-test was used to determine difference between groups while
Cox regression analysis was used to determine its signiﬁcance as a predictor of
mortality.
Results: Pulmonary hypertension was present in 15% of the patients. The Tp-e/QTc
ratio in scleroderma patients without pulmonary hypertension was 28.34.9 and that
in patients with pulmonary hypertension was 31.45.7. The difference between the
two groups was statistically signiﬁcant (p¼0.007). This ratio was found to be
a predictor of mortality in those with pulmonary hypertension (p¼0.029) but it did not
predict mortality in those without pulmonary hypertension (p¼0.489). The risk of
mortality was found to be increased in patients with a Tp-e/QTc ratio > 0.35 as
compared to those with a ratio of <0.35 (Fig. 1).
Dıscussıon: Non-invasive methods of determining arrhythmia risk has been receiving
increased attention in recent years. Tp-e/QTc ratio is a new parameter that predicts
arrhythmia risk in different spectrum of diseases. In this study, presence of pulmonary
hypertension in scleroderma patients was found to be a risk factor for cardiac
arrhythmias and a signiﬁcant correlation was found between this simple and easy ECG
parameter and mortality. Patients with a high Tp-e/QTc ratio must be closely and
carefully followed-up for cardiac complications.l 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTERS
